Lifeward (LFWD) Assets Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.00% |
| Dec 31, 2025 | -24.89% |
| Sep 30, 2025 | -49.38% |
| Jun 30, 2025 | -47.48% |
| Mar 31, 2025 | -47.83% |
| Dec 31, 2024 | -51.75% |
| Sep 30, 2024 | -33.88% |
| Jun 30, 2024 | -22.53% |
| Mar 31, 2024 | -19.95% |
| Dec 31, 2023 | -14.88% |
| Sep 30, 2023 | -14.30% |
| Jun 30, 2023 | -23.30% |
| Mar 31, 2023 | -23.36% |
| Dec 31, 2022 | -21.65% |
| Sep 30, 2022 | -18.18% |
| Jun 30, 2022 | 19.65% |
| Mar 31, 2022 | 20.70% |
| Dec 31, 2021 | 237.59% |
| Sep 30, 2021 | 276.30% |
| Jun 30, 2021 | 215.80% |
| Mar 31, 2021 | 195.68% |
| Dec 31, 2020 | 15.16% |
| Sep 30, 2020 | -7.71% |
| Jun 30, 2020 | -28.98% |
| Mar 31, 2020 | 48.02% |
| Dec 31, 2019 | 62.89% |
| Sep 30, 2019 | 139.40% |
| Jun 30, 2019 | 87.79% |
| Mar 31, 2019 | -3.86% |
| Dec 31, 2018 | -34.56% |
| Sep 30, 2018 | -44.73% |
| Jun 30, 2018 | -30.00% |
| Mar 31, 2018 | -29.89% |
| Dec 31, 2017 | -28.02% |
| Sep 30, 2017 | 3.19% |
| Jun 30, 2017 | -1.29% |
| Mar 31, 2017 | -18.73% |
| Dec 31, 2016 | 24.20% |
| Sep 30, 2016 | -36.85% |
| Jun 30, 2016 | -37.02% |
| Dec 31, 2015 | -46.35% |
| Sep 30, 2015 | -38.01% |
| Dec 31, 2014 | 331.01% |